Warsame, Rahma
LaPlant, Betsy
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Laumann, Kristina
Perez Burbano, Gabriela
Buadi, Francis K.
Gertz, Morie A.
Kyle, Robert A.
Lacy, Martha Q.
Dingli, David
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Hayman, Suzanne R.
Kapoor, Prashant
Hwa, Yi L.
Fonder, Amie
Hobbs, Miriam
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Lust, John
Russell, Stephen J.
Zeldenrust, Steven
Lin, Yi
Muchtar, Eli
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Vincent Rajkumar, S. http://orcid.org/0000-0002-5862-1833
Dispenzieri, Angela
Article History
Received: 2 May 2019
Accepted: 11 December 2019
First Online: 8 January 2020
Conflict of interest
: All conflicts of interest have been disclosed: M.A.G. reports research support from Spectrum, research support from Amyloidosis Foundation; research support from International Waldenstrom Foundation, research support from NCI SPORE MM SPORE 5P50 CA186781-04, personal fees from Ionis/Akcea, personal fees from Alnylam, personal fees from Prothena, personal fees from Celgene, personal fees from Janssen, personal fees from Spectrum, personal fees from Annexon, personal fees from Appellis, personal fees from Amgen, personal fees from Medscape, personal fees from Physicians Education Resource, personal fees for Data Safety Monitoring board from Abbvie, personal fees from Research to Practice, speaker fees from Teva, speaker fees from Johnson and Johnson; speaker fees from Medscape, speaker fees from DAVA oncology, advisory board participation for Pharmacyclics, advisory board participation for Proclara, development of educational materials for i3Health, royalties from Springer Publishing outside the submitted work; S.K.K reports research support from Abbvie, research support from Celgene, research support from Janssen, research support from Merck, research support from Novartis, research support from Roche, research support from Sanofi, research support from Takeda, personal fees from Oncopeptides, personal fees from Adaptive, grants from KITE, grants from Medimmune/Astra Zeneca, advisory board participation for Celgene, advisory board participation for Takeda, advisory board participation for Janssen, advisory board participation for KITE, advisory board participation for Merck, advisory board participation for Abbvie, advisory board participation for Medimmune, advisory board participation for Genentech, advisory board participation for Amgen, honorarium for educational events for Dr. Reddy’s lab, honorarium for educational events for Ono Pharmaceuticals outside the submitted work; Y.L. reports advisory board participation for Celgene outside the submitted work; A.D. reports research support from Takeda, research support from Pfizer, research support from Prothena, research support from Celgene, research support from Alnylam, research support from Janssen, advisory board participation for Alnylam outside the submitted work; P.K. reports research support from Celgene, research support from Takeda, research support from Janssen, research support from Glaxo Smith Kline (GSK), research support from Sanofi, honorarium from Celgene, honorarium from Takeda outside the submitted work; M.Q.L. reports research support from Celgene outside the submitted work; N.L. reports advisory board participation for Takeda, advisory board participation for Prothena outside the submitted work; R.W., F.K.B., R.A.K., D.D., S.R.H., W.I.G., T.K., J.L., S.J.R., S.Z., E.M., R.S.G., V.R., B.L., K.L., G.P.B., Y.L.H., A.F. and M.H. declare no potential conflict of interest.